Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
Income from Continuing Operations
|
Compugen Ltd
Income from Continuing Operations Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Income from Continuing Operations
-$18.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-6%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Income from Continuing Operations
-$8.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Income from Continuing Operations
-₪27.5m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
See Also
What is Compugen Ltd's Income from Continuing Operations?
Income from Continuing Operations
-18.8m
USD
-18.8m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Income from Continuing Operations amounts to -18.8m USD.
What is Compugen Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-6%
-6%
Over the last year, the Income from Continuing Operations growth was 44%. The average annual Income from Continuing Operations growth rates for Compugen Ltd have been 14% over the past three years , 4% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
